Z. Cholisoh, Hidayah Karuniawati, Tanti Azizah, Zaenab Zaenab, Laila Nur Hekmah
{"title":"Factors Affecting Non-Adherence to Secondary Stroke Prevention Therapy in Ischemic Stroke Patients","authors":"Z. Cholisoh, Hidayah Karuniawati, Tanti Azizah, Zaenab Zaenab, Laila Nur Hekmah","doi":"10.22146/jmpf.34434","DOIUrl":null,"url":null,"abstract":"Stroke is cardiovascular disease that causes the world's highest disability and is the most prevalence disease after heart disease and cancer. Stroke is caused by circulatory disorders with 80% of the sufferers are diagnosed with ischemic stroke and 20% of them are diagnosed with hemorrhagic stroke. Patients who survive from the first stroke have high risk to have recurrent stroke. American Heart Association/American Stroke Association and Perhimpunan Dokter Spesialis Syaraf Indonesia recommend secondary stroke prevention therapy including antiplatelet/anticoagulant, antihypertensive agents, and antidislipidemia to minimalize the risk of recurrent stroke. Secondary stroke prevention therapy is only the first step. Patients need to be adhere to those therapies. The non-adherence will increase the risk of recurrent stroke. The study aimed to determine factors which causing the non-adherence to secondary prevention therapy in patients with ischemic stroke. This was a case control study with concecutive sampling method by interviewing patients who met the inclusion criterias i.e., had been diagnosed and were inpatients due to ischemic stroke, but in the time of interview patients were outpatients, patients were able to communicate and agree to participate in the study.Data was analized by bivariate / chi square test and multivariate logistic regression test. During the study period, 184 respondents met the inclusion criterias. Factors affecting non-adherence in the use of secondary prevention therapy were No one reminded to take medicine p = 0.03; OR 4.51, denial of the disease p = 0,036 OR 214, and tired of taking medicine p = 0,045 OR 1,97.","PeriodicalId":33008,"journal":{"name":"Jurnal Manajemen dan Pelayanan Farmasi","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Manajemen dan Pelayanan Farmasi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22146/jmpf.34434","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Stroke is cardiovascular disease that causes the world's highest disability and is the most prevalence disease after heart disease and cancer. Stroke is caused by circulatory disorders with 80% of the sufferers are diagnosed with ischemic stroke and 20% of them are diagnosed with hemorrhagic stroke. Patients who survive from the first stroke have high risk to have recurrent stroke. American Heart Association/American Stroke Association and Perhimpunan Dokter Spesialis Syaraf Indonesia recommend secondary stroke prevention therapy including antiplatelet/anticoagulant, antihypertensive agents, and antidislipidemia to minimalize the risk of recurrent stroke. Secondary stroke prevention therapy is only the first step. Patients need to be adhere to those therapies. The non-adherence will increase the risk of recurrent stroke. The study aimed to determine factors which causing the non-adherence to secondary prevention therapy in patients with ischemic stroke. This was a case control study with concecutive sampling method by interviewing patients who met the inclusion criterias i.e., had been diagnosed and were inpatients due to ischemic stroke, but in the time of interview patients were outpatients, patients were able to communicate and agree to participate in the study.Data was analized by bivariate / chi square test and multivariate logistic regression test. During the study period, 184 respondents met the inclusion criterias. Factors affecting non-adherence in the use of secondary prevention therapy were No one reminded to take medicine p = 0.03; OR 4.51, denial of the disease p = 0,036 OR 214, and tired of taking medicine p = 0,045 OR 1,97.
中风是导致世界上残疾率最高的心血管疾病,也是仅次于心脏病和癌症的最常见疾病。中风是由循环系统疾病引起的,80%的患者被诊断为缺血性中风,20%的患者被确诊为出血性中风。从第一次中风中幸存下来的患者复发中风的风险很高。美国心脏协会/美国中风协会和印度尼西亚Perhimpunan Dokter Spesialis Syaraf建议进行二次中风预防治疗,包括抗血小板/抗凝剂、抗高血压药物和抗脂血症,以将复发性中风的风险降至最低。二级脑卒中预防治疗只是第一步。患者需要坚持这些疗法。不坚持会增加复发性中风的风险。本研究旨在确定缺血性脑卒中患者不坚持二级预防治疗的因素。这是一项采用连续抽样方法的病例对照研究,通过访谈符合纳入标准的患者,即已被诊断为缺血性中风住院患者,但在访谈时,患者是门诊患者,患者能够沟通并同意参与研究。数据采用双变量/卡方检验和多变量逻辑回归检验进行分析。在研究期间,184名受访者符合纳入标准。影响二级预防治疗不依从性的因素是:没有人被提醒服药p=0.03;OR 4.51,否认疾病p=0036 OR 214,厌倦服药p=0045 OR 1,97。